Miscellaneous Quiz / Thera2-ThromboembolicDrugs

Random Miscellaneous Quiz

Can you name the Thera2-AnticoagulantDrugs?

Quiz not verified by Sporcle

Forced Order
Also try: Click a Jim
Challenge
Share
Tweet
Embed
Score 0/69 Timer 20:00
HintAnswer
T or F: Cholestyramine interferes with warfarin absorption.
Lepirudin is indicated for ____ treatment in HIT patients.
Warfarin inhibits vitamin K _______ reductase.
Dabigatran dosing is: ___mg PO BID.
Warfarin dosing is: initiate __mg PO after UFH or LMWH initiated.
Normal prothrombin time is __-__ seconds (enter as # - #)
T or F: Phytonadione (Vitamin K analog) is an antidote to warfarin.
T or F: Enoxaparin requires dose adjustment in renal impairment.
The goal aPTT for UFH therapy is ___-___. (enter as # - #)
Warfarin works by interfering with _______ synthesis of vitamin K dependent clotting factors.
T or F: UFH treatment doses are given as a continuous IV.
T or F: Argatroban is given as a continuous IV infusion and requires dose adjustment for hepatic impairment.
T or F: If a patient experiences HIT II on UFH therapy, stop treatment immediately.
UFH works by binding to ______, converting it from a slow inhibitor to a rapid inhibitor of thrombin.
T or F: Fondaparinux administration might produce injection site reactions.
T or F: Patient education regarding enoxaparin should include teaching the patient how to inject the drug.
T or F: Fondaparinux has more thrombocytopenia than LMWH.
Warfarin's R-isomer is metabolized by CYP450 3A4 & ___
Enoxaparin's starting TREATMENT dose is: ___mg/kg SQ BID or 1.5mg/kg daily.
Brand Name Fondaparinux
T or F: Fondaparinux treatment dosing is weight based.
Monitoring parameters of Warfarin are: prothrombin time and ____
Fondaparinux monitoring may include: ___
HintAnswer
UFH target patients include all except: (a) immobile (b) post-op (c) trauma (d) spinal cord injuries (e) all of the above are target patients.
Warfarin interferes with clotting factors: ___, ___, ___, and ___. (enter in order of longest to shortest time; separate answers by commas))
Toxic monitoring parameters of Enoxaparin include: ____ and signs of bleeding.
Dabigatran is indicated for: ____ ____
Some side effects of Enoxaparin include: bleeding, thrombocytopenia, and ____ at the injection site.
Lepirudin's dose is given as a ______ infusion.
Side effects of UFH therapy include: bleeding, _________, HIT I, HIT II, and osteopenia.
T or F: Enoxaparin inhibits factor II more than factor X.
UFH treatment dosing is: ___units/kg bolus followed by 18 units/kg/hour.
Normal INR is __-__ (enter as # - #)
UFH prophylactic dosing is: _____ units SQ every 8-12 hours.
T or F: Possible drug interactions with Dabigatran include p-glycoprotein inhibitors or inducers, e.g. PPIs and antacids.
When using Enoxaparin, anti-Xa should be monitored if the patient is _____, pregnant, or has renal insufficiency.
Brand Name Warfarin
UFH toxic monitoring includes: bleeding complications and ___ every other day x 2 weeks or until stopped
Argatroban is indicated for HIT or ____
Treatment dose of Fondaparinux for a patient weighing 50-100kg is: ___mg
Brand Name Enoxaparin
Treatment dose of Fondaparinux for a patient weighing > 100kg is: ___mg
T or F: If a patient experiences HIT I on UFH therapy, stop the treatment stat.
Lepirudin, Argatroban, and Dabigatran all work by directly inhibiting _______.
UFH therapeutic monitoring for treatment doses includes: ___
Warfarin also interferes with endogenous anticoagulant proteins ___ & S.
HintAnswer
T or F: UFH therapeutic uses include: prophylaxis & treatment of DVT/PE, acute coronary syndromes, and atrial fibrillation.
Heparin's antidote
Fondaparinux works through anti-___a activity only.
Fondaparinux is used for prophylaxis & treatment of DVT/PE, ACS, and ___ (not FDA approved)
Brand Name Dabigatran
UFH inactivates factors: ___ (most), X, IX, XI, and XII.
When on Lepirudin, ____ should be monitored every 4 hours until stable.
Enoxaparin works by enhancing the activity of _____.
Enoxaparin is indicated for the treatment & prophylaxis of DVT/PE and acute MI/_____ angina.
Argatroban might cause a false elevation in INR of __-__ points. (enter as # - #)
Brand Name Lepirudin
Treatment dose of Fondaparinux for a patient < 50kg is: ___mg
Enoxaparin's starting PROPHYLACTIC dose is: ___mg SQ BID or 40mg SQ daily.
Brand Name UFH
Warfarin's S-isomer is metabolized by CYP450 ___.
Phytonadione Brand Name
Dabigatran dosing in renal impairment (CrCl 15-30mL/min) is ___mg PO BID
T or F: 2C9 & 3A4 inhibitors and decreased vitamin K DECREASE the effect of warfarin.
Possible side effects of Warfarin include: bleeding, ____ necrosis, and purple toe syndrome.
T or F: Direct thrombin inhibitors have a reversal agent.
T or F: Warfarin is approved for prophylaxis & treatment of DVT/PE, acute MI, prosthetic heart valves, atrial fibrillation, and inherited clotting disorders.
Fondaparinux prophylactic dosing is: ___mg SQ every 24 hours
Side effects of Dabigatran are bleeding and _________.

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras

Top Quizzes Today


Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.